Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1982 Feb;106(2):187–203.

Human T-cell malignancies: Correlative clinical, histopathologic, immunologic, and cytochemical analysis of 23 cases.

D M Knowles 2nd, J P Halper
PMCID: PMC1916190  PMID: 6978074

Abstract

Twenty-three T-cell neoplasms were investigated for their reactivity with the OKT monoclonal antibodies and expression of certain cytochemical markers. Fourteen neoplasms with diverse histopathologic features, T-cell chronic lymphocytic leukemia, mycosis fungoides, the Sézary syndrome, T-immunoblastic sarcoma, and a pleomorphic large-cell lymphoma, expressed the T helper cell phenotype, OKT3+T4+. Nine other neoplasms displayed marked inter- and intra- tumor heterogeneity. Seven of these cases, lymphoblastic lymphoma, T-cell acute lymphoblastic leukemia, and tumors with feature of T-immunoblastic sarcoma or the multilobated lymphoma of Pinkus, expressed intrathymic phenotypes. The other 2 cases, a lymphoblastic lymphoma and a so-called Lennert's lymphoma, expressed the previously undescribed OKT3+T10+ phenotype. These studies demonstrate that the T-cell malignancies are divisible into phenotypes corresponding to normal maturational stages of T-cell differentiation and functionally distinct T-cell subsets. Such studies should provide a basis for understanding the biologic heterogeneity, clinical diversity, and significance of the variable cytomorphologic characteristics of T-cell malignant tumors and assist in the further delineation of normal human T-cell heterogeneity.

Full text

PDF
187

Images in this article

193Figure 1
on p.193
194Figure 2
on p.194
194Figure 3
on p.194
195Figure 4
on p.195
195Figure 5
on p.195
196Figure 6
on p.196
197Figure 7
on p.197
198Figure 8
on p.198

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aisenberg A. C., Wilkes B. M. Unusual human lymphoma phenotype defined by monoclonal antibody. J Exp Med. 1980 Oct 1;152(4):1126–1131. doi: 10.1084/jem.152.4.1126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barrett S. G., Schwade J. G., Ranken R., Kadin M. E. Lymphoblasts with both T and B markers in childhood leukemia and lymphoma. Blood. 1977 Jul;50(1):71–79. [PubMed] [Google Scholar]
  3. Basso G., Cocito M. G., Semenzato G., Pezzutto A., Zanesco L. Cytochemical study of thymocytes and T lymphocytes. Br J Haematol. 1980 Apr;44(4):577–582. doi: 10.1111/j.1365-2141.1980.tb08712.x. [DOI] [PubMed] [Google Scholar]
  4. Borella L., Sen L. E receptors on blasts from untreated acute lymphocytic leukemia (ALL): comparison of temperature dependence of E rosettes formed by normal and leukemic lymphoid cells. J Immunol. 1975 Jan;114(1 Pt 1):187–190. [PubMed] [Google Scholar]
  5. Boumsell L., Bernard A., Reinherz E. L., Nadler L. M., Ritz J., Coppin H., Richard Y., Dubertret L., Valensi F., Degos L. Surface antigens on malignant Sézary and T-CLL cells correspond to those of mature T cells. Blood. 1981 Mar;57(3):526–530. [PubMed] [Google Scholar]
  6. Broder S., Bunn P. A., Jr Cutaneous T-cell lymphomas. Semin Oncol. 1980 Sep;7(3):310–331. [PubMed] [Google Scholar]
  7. Broder S., Edelson R. L., Lutzner M. A., Nelson D. L., MacDermott R. P., Durm M. E., Goldman C. K., Meade B. D., Waldmann T. A. The Sézary syndrome: a malignant proliferation of helper T cells. J Clin Invest. 1976 Dec;58(6):1297–1306. doi: 10.1172/JCI108585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Broder S., Poplack D., Whang-Peng J., Durm M., Goldman C., Muul L., Waldmann T. A. Characterization of a suppressor-cell leukemia. Evidence for the requirement of an interaction of two T cells in the development of human suppressor effector cells. N Engl J Med. 1978 Jan 12;298(2):66–72. doi: 10.1056/NEJM197801122980202. [DOI] [PubMed] [Google Scholar]
  9. Burke J. S., Butler J. J. Malignant lymphoma with a high content of epitheloid histiocytes (Lennert's lymphoma). Am J Clin Pathol. 1976 Jul;66(1):1–9. doi: 10.1093/ajcp/66.1.1. [DOI] [PubMed] [Google Scholar]
  10. Evans R. L., Faldetta T. J., Humphreys R. E., Pratt D. M., Yunis E. J., Schlossman S. F. Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens. J Exp Med. 1978 Nov 1;148(5):1440–1445. doi: 10.1084/jem.148.5.1440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Evans R. L., Lazarus H., Penta A. C., Schlossman S. F. Two functionally distinct subpopulations of human T cells that collaborate in the generation of cytotoxic cells responsible for cell-mediated lympholysis. J Immunol. 1978 Apr;120(4):1423–1428. [PubMed] [Google Scholar]
  12. Fu S. M., Chiorazzi N., Wang C. Y., Montrazeri G., Kunkel H. G., Ko H. S., Gottlieb A. B. Ia-bearing T lymphocytes in man. Their identification and role in the generation of allogeneic helper activity. J Exp Med. 1978 Nov 1;148(5):1423–1428. doi: 10.1084/jem.148.5.1423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Halper J. P., Knowles D. M., 2nd, Wang C. Y. Ia antigen expression by human malignant lymphomas: correlation with conventional lymphoid markers. Blood. 1980 Mar;55(3):373–382. [PubMed] [Google Scholar]
  14. Haynes B. F., Metzgar R. S., Minna J. D., Bunn P. A. Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells. N Engl J Med. 1981 May 28;304(22):1319–1323. doi: 10.1056/NEJM198105283042202. [DOI] [PubMed] [Google Scholar]
  15. Hoffman R., Kopel S., Hsu S. D., Dainiak N., Zanjani E. D. T cell chronic lymphocytic leukemia: presence in bone marrow and peripheral blood of cells that suppress erythropoiesis in vitro. Blood. 1978 Jul;52(1):255–260. [PubMed] [Google Scholar]
  16. Huber B., Devinsky O., Gershon R. K., Cantor H. Cell-mediated immunity: delayed-type hypersensitivity and cytotoxic responses are mediated by different T-cell subclasses. J Exp Med. 1976 Jun 1;143(6):1534–1539. doi: 10.1084/jem.143.6.1534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Jaffe E. S., Berard C. W. Lymphoblastic lymphoma, a term rekindled with new precision. Ann Intern Med. 1978 Sep;89(3):415–417. doi: 10.7326/0003-4819-89-3-415. [DOI] [PubMed] [Google Scholar]
  18. Jaffe E. S., Braylan R. C., Frank M. M., Green I., Berard C. W. Heterogeneity of immunologic markers and surface morphology in childhood lymphoblastic lymphoma. Blood. 1976 Aug;48(2):213–222. [PubMed] [Google Scholar]
  19. Janossy G., Tidman N., Selby W. S., Thomas J. A., Granger S., Kung P. C., Goldstein G. Human T lymphocytes of inducer and suppressor type occupy different microenvironments. Nature. 1980 Nov 6;288(5786):81–84. doi: 10.1038/288081a0. [DOI] [PubMed] [Google Scholar]
  20. Katayama I., Li C. Y., Yam L. T. Histochemical study of acid phosphatase isoenzyme in leukemic reticuloendotheliosis. Cancer. 1972 Jan;29(1):157–164. doi: 10.1002/1097-0142(197201)29:1<157::aid-cncr2820290124>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  21. Knowles D. M., 2nd, Halper J. P. Human medullary and cortical thymocytes are distinguishable according to the presence or absence of cytochemically demonstrable acid alpha-naphthyl acetate esterase (ANAE) activity. J Immunol. 1980 Dec;125(6):2823–2825. [PubMed] [Google Scholar]
  22. Knowles D. M., Hoffman T., Ferrarini M., Kunkel H. G. The demonstration of acid alpha-naphthyl acetate esterase activity in human lymphocytes: usefulness as a T-cell marker. Cell Immunol. 1978 Jan;35(1):112–123. doi: 10.1016/0008-8749(78)90131-4. [DOI] [PubMed] [Google Scholar]
  23. Kung P. C., Berger C. L., Goldstein G., LoGerfo P., Edelson R. L. Cutaneous T cell lymphoma: characterization by monoclonal antibodies. Blood. 1981 Feb;57(2):261–266. [PubMed] [Google Scholar]
  24. Kung P., Goldstein G., Reinherz E. L., Schlossman S. F. Monoclonal antibodies defining distinctive human T cell surface antigens. Science. 1979 Oct 19;206(4416):347–349. doi: 10.1126/science.314668. [DOI] [PubMed] [Google Scholar]
  25. Lawrence E. C., Broder S., Jaffe E. S., Braylan R. C., Dobbins W. O., Young R. C., Waldmann T. A. Evolution of a lymphoma with helper T cell characteristics in Sézary syndrome. Blood. 1978 Sep;52(3):481–492. [PubMed] [Google Scholar]
  26. Lennert's lymphoma, a T-cell neoplasm. Am J Clin Pathol. 1978 Jun;69(6):643–647. [PubMed] [Google Scholar]
  27. Long J. C., Aisenberg A. C. Richter's syndrome. A terminal complication of chronic lymphocytic leukemia with distinct clinicopathologic features. Am J Clin Pathol. 1975 Jun;63(6):786–795. doi: 10.1093/ajcp/63.6.786. [DOI] [PubMed] [Google Scholar]
  28. Lukes R. J., Collins R. D. New approaches to the classification of the lymphomata. Br J Cancer Suppl. 1975 Mar;2:1–28. [PMC free article] [PubMed] [Google Scholar]
  29. Lukes R. J., Taylor C. R., Parker J. W., Lincoln T. L., Pattengale P. K., Tindle B. H. A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias. Am J Pathol. 1978 Feb;90(2):461–486. [PMC free article] [PubMed] [Google Scholar]
  30. Lutzner M., Edelson R., Schein P., Green I., Kirkpatrick C., Ahmed A. Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders. Ann Intern Med. 1975 Oct;83(4):534–552. doi: 10.7326/0003-4819-83-4-534. [DOI] [PubMed] [Google Scholar]
  31. Machin G. A., Halper J. P., Knowles D. M., 2nd Cytochemically demonstrable B-glucuronidase activity in normal and neoplastic human lymphoid cells. Blood. 1980 Dec;56(6):1111–1119. [PubMed] [Google Scholar]
  32. Moretta L., Webb S. R., Grossi C. E., Lydyard P. M., Cooper M. D. Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG. J Exp Med. 1977 Jul 1;146(1):184–200. doi: 10.1084/jem.146.1.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Murphy G. F., Bhan A. K., Sato S., Mihm M. C., Jr, Harrist T. J. A new immunologic marker for human Langerhans cells. N Engl J Med. 1981 Mar 26;304(13):791–792. doi: 10.1056/NEJM198103263041320. [DOI] [PubMed] [Google Scholar]
  34. Nadler L. M., Reinherz E. L., Weinstein H. J., D'Orsi C. J., Schlossman S. F. Heterogeneity of T-cell lymphoblastic malignancies. Blood. 1980 May;55(5):806–810. [PubMed] [Google Scholar]
  35. Nathwani B. N., Kim H., Rappaport H. Malignant lymphoma, lymphoblastic. Cancer. 1976 Aug;38(2):964–983. doi: 10.1002/1097-0142(197608)38:2<964::aid-cncr2820380248>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  36. Pinkus G. S., Said J. W., Hargreaves H. Malignant lymphoma, T-cell type. A distinct morphologic variant with large multilobated nuclei, with a report of four cases. Am J Clin Pathol. 1979 Oct;72(4):540–550. doi: 10.1093/ajcp/72.4.540. [DOI] [PubMed] [Google Scholar]
  37. Poppema S., Bhan A. K., Reinherz E. L., McCluskey R. T., Schlossman S. F. Distribution of T cell subsets in human lymph nodes. J Exp Med. 1981 Jan 1;153(1):30–41. doi: 10.1084/jem.153.1.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Ranki A., Tötterman T. H., Häyry P. Identification of resting human T and B lymphocytes by acid alpha-naphthyl acetate esterase staining combined with rosette formation with Staphylococcus aureus strain Cowan 1. Scand J Immunol. 1976;5(10):1129–1138. doi: 10.1111/j.1365-3083.1976.tb00254.x. [DOI] [PubMed] [Google Scholar]
  39. Rappaport H., Thomas L. B. Mycosis fungoides: the pathology of extracutaneous involvement. Cancer. 1974 Oct;34(4):1198–1229. doi: 10.1002/1097-0142(197410)34:4<1198::aid-cncr2820340431>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  40. Reinherz E. L., Kung P. C., Goldstein G., Levey R. H., Schlossman S. F. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1588–1592. doi: 10.1073/pnas.77.3.1588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Reinherz E. L., Nadler L. M., Rosenthal D. S., Moloney W. C., Schlossman S. F. T-cell-subset characterization of human T-CLL. Blood. 1979 Jun;53(6):1066–1075. [PubMed] [Google Scholar]
  42. Reinherz E. L., Schlossman S. F. Current concepts in immunology: Regulation of the immune response--inducer and suppressor T-lymphocyte subsets in human beings. N Engl J Med. 1980 Aug 14;303(7):370–373. doi: 10.1056/NEJM198008143030704. [DOI] [PubMed] [Google Scholar]
  43. Reinherz E. L., Schlossman S. F. The differentiation and function of human T lymphocytes. Cell. 1980 Apr;19(4):821–827. doi: 10.1016/0092-8674(80)90072-0. [DOI] [PubMed] [Google Scholar]
  44. Saxon A., Stevens R. H., Golde D. W. Helper and suppressor t-lymphocyte leukemia in ataxia telangiectasia. N Engl J Med. 1979 Mar 29;300(13):700–704. doi: 10.1056/NEJM197903293001303. [DOI] [PubMed] [Google Scholar]
  45. Siegal F. P., Filippa D. A., Koziner B. Surface markers in leukemias and lymphomas. Am J Pathol. 1978 Feb;90(2):451–460. [PMC free article] [PubMed] [Google Scholar]
  46. Stein H., Petersen N., Gaedicke G., Lennert K., Landbeck G. Lymphoblastic lymphoma of convoluted or acid phosphatase type-a tumor of T precursor cells. Int J Cancer. 1976 Mar 15;17(3):292–295. doi: 10.1002/ijc.2910170303. [DOI] [PubMed] [Google Scholar]
  47. Waldron J. A., Leech J. H., Glick A. D., Flexner J. M., Collins R. D. Malignant lymphoma of peripheral T-lymphocyte origin: immunologic, pathologic, and clinical features in six patients. Cancer. 1977 Oct;40(4):1604–1617. doi: 10.1002/1097-0142(197710)40:4<1604::aid-cncr2820400433>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  48. Worman C. P., Burns G. F., Barker C. R. Evidence for the presence of a receptor for IgM on the pathological cells of Sézary's syndrome. Clin Exp Immunol. 1978 Mar;31(3):391–396. [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES